FDA REFORM DEBATE MAY SPUR "MORE INFORMED" OVERSIGHT OF FDA BY CONGRESS, SENATE STAFFER SAYS; PDUFA REAUTHORIZATION HAS SET FIVE-YEAR CYCLE FOR FD&C ACT REVIEW